{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:05:10Z","timestamp":1775887510793,"version":"3.50.1"},"reference-count":40,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>It is known that a subset of cases of classic Hodgkin lymphoma (CHL) with B-cell\u2013rich nodules (lymphocyte-rich CHL) exhibits morphologic and immunophenotypic features that overlap with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), raising diagnostic difficulties that can be resolved in most cases by performing an adequate battery of immunohistochemical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To fully characterize cases of T-cell\u2013rich Hodgkin lymphoma where a specific diagnosis of NLPHL (ie, pattern D) or CHL could not be made even after complete immunophenotypic investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>The clinical, immunomorphologic, and molecular (when applicable) presentation of 3 cases of T-cell\u2013rich Hodgkin lymphoma was thoroughly investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>These 3 cases harbored lymphocyte-predominant\u2013like and Hodgkin and Reed-Sternberg\u2013like cells that partially expressed B-cell and CHL markers and were negative for Epstein-Barr virus\u2013encoded small RNA, in a T-cell\u2013rich background with residual follicular dendritic cell meshworks; 1 case had frequent and the other 2 cases scant\/absent eosinophils and plasma cells. Two patients with advanced-stage (III or IV) disease presented with axillary and supraclavicular lymphadenopathy, respectively, and without B symptoms. These patients underwent NLPHL-like therapeutic management with 6 cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride [hydroxydaunorubicin], vincristine sulfate [Oncovin], and prednisone) chemotherapy; both are in complete remission 7 years posttherapy. One patient presented with stage I disease involving an internal mammary lymph node without B-symptoms and was treated with surgical excision alone; this patient is also in complete remission 1 year later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>These cases illustrate overlapping features of T-cell\u2013rich NLPHL and CHL with neoplastic cells expressing both B-cell program and CHL markers. This underrecognized overlap has not been fully illustrated in the literature, although it portrays a therapeutic challenge. These neoplasms may deserve in-depth investigation in the future that may bring up diagnostic or theragnostic implications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2023-0133-oa","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T07:01:17Z","timestamp":1701932477000},"page":"914-920","source":"Crossref","is-referenced-by-count":2,"title":["T-Cell\u2013Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features"],"prefix":"10.5858","volume":"148","author":[{"given":"Siba","family":"El Hussein","sequence":"first","affiliation":[{"name":"the Department of Pathology (El Hussein, Burack, Evans), and the Wilmot Cancer Institute (Friedberg), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Zahra","family":"Jelloul","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[{"name":"the Department of Pathology (El Hussein, Burack, Evans), and the Wilmot Cancer Institute (Friedberg), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Richard","family":"Burack","sequence":"additional","affiliation":[{"name":"the Department of Pathology (El Hussein, Burack, Evans), and the Wilmot Cancer Institute (Friedberg), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Evans","sequence":"additional","affiliation":[{"name":"the Department of Pathology (El Hussein, Burack, Evans), and the Wilmot Cancer Institute (Friedberg), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Jelloul, Wang, Loghavi, Miranda, Xu, Medeiros)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"issue":"7","key":"2024080115202971300_i1543-2165-148-8-914-b01","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2024080115202971300_i1543-2165-148-8-914-b02","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2024080115202971300_i1543-2165-148-8-914-b03","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"26","key":"2024080115202971300_i1543-2165-148-8-914-b04","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2024080115202971300_i1543-2165-148-8-914-b05","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bjh.13540","article-title":"Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma\u2014a review of clinical outcome based on the histological variants","volume":"171","author":"Shankar","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2024080115202971300_i1543-2165-148-8-914-b06","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjh.15658","article-title":"The translational science of Hodgkin lymphoma","volume":"184","author":"Cirillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"2024080115202971300_i1543-2165-148-8-914-b07","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin\u2019s disease and lymphocyte-rich classical Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"issue":"9","key":"2024080115202971300_i1543-2165-148-8-914-b08","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/PAS.0000000000001917","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodular sclerosis: an underrecognized feature associated with pattern D","volume":"46","author":"El Hussein","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2024080115202971300_i1543-2165-148-8-914-b09","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anndiagpath.2019.02.001","article-title":"American Registry of Pathology expert opinions: immunohistochemical evaluation of classic Hodgkin lymphoma","volume":"39","author":"O\u2019Malley","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"2024080115202971300_i1543-2165-148-8-914-b10","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"issue":"8","key":"2024080115202971300_i1543-2165-148-8-914-b11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin\u2019s lymphoma: distinctive tumor and microenvironment markers","volume":"22","author":"Nam-Cha","year":"2009","journal-title":"Mod Pathol"},{"issue":"10","key":"2024080115202971300_i1543-2165-148-8-914-b12","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"2024080115202971300_i1543-2165-148-8-914-b13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12308-011-0135-3","article-title":"Clonal antigen receptor gene PCR products outside the expected size range","volume":"5","author":"Rothberg","year":"2012","journal-title":"J Hematopathol"},{"key":"2024080115202971300_i1543-2165-148-8-914-b14","article-title":"T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis [published online July 13, 2023]","author":"Fang","journal-title":"Leukemia"},{"issue":"7","key":"2024080115202971300_i1543-2165-148-8-914-b15","first-page":"1644","article-title":"Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin\u2019s lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin\u2019s lymphoma","volume":"63","author":"Brauninger","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"2024080115202971300_i1543-2165-148-8-914-b16","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"2024080115202971300_i1543-2165-148-8-914-b17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/ajh.25972","article-title":"Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse","volume":"95","author":"Bein","year":"2020","journal-title":"Am J Hematol"},{"issue":"20","key":"2024080115202971300_i1543-2165-148-8-914-b18","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3390\/cancers13205208","article-title":"Landscape of 4D cell interaction in Hodgkin and non-Hodgkin lymphomas","volume":"13","author":"Hartmann","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2024080115202971300_i1543-2165-148-8-914-b19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"issue":"10","key":"2024080115202971300_i1543-2165-148-8-914-b20","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"issue":"5","key":"2024080115202971300_i1543-2165-148-8-914-b21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/PAS.0b013e3182147f91","article-title":"Coexisting and clonally identical classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma","volume":"35","author":"Song","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2024080115202971300_i1543-2165-148-8-914-b22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000478-199304000-00007","article-title":"Coexistence of nodular lymphocyte predominance Hodgkin\u2019s disease and Hodgkin\u2019s disease of the usual type","volume":"17","author":"Gelb","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2024080115202971300_i1543-2165-148-8-914-b23","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X","article-title":"Hodgkin\u2019s disease, lymphocytic predominance nodular: increased risk for subsequent non-Hodgkin\u2019s lymphomas","volume":"51","author":"Miettinen","year":"1983","journal-title":"Cancer"},{"issue":"4","key":"2024080115202971300_i1543-2165-148-8-914-b24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.2242","article-title":"Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma","volume":"213","author":"Tedoldi","year":"2007","journal-title":"J Pathol"},{"issue":"6","key":"2024080115202971300_i1543-2165-148-8-914-b25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2020-0135-OA","article-title":"CD20-negative nodular lymphocyte-predominant Hodgkin lymphoma: a 20-year consecutive case series from a tertiary cancer center","volume":"145","author":"Menke","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2024080115202971300_i1543-2165-148-8-914-b26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12308-011-0104-x","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells","volume":"4","author":"Seliem","year":"2011","journal-title":"J Hematop"},{"issue":"5","key":"2024080115202971300_i1543-2165-148-8-914-b27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2559.2011.03829.x","article-title":"CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"58","author":"Venkataraman","year":"2011","journal-title":"Histopathology"},{"issue":"12","key":"2024080115202971300_i1543-2165-148-8-914-b28","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/cancers13123021","article-title":"Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics","volume":"13","author":"Younes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2024080115202971300_i1543-2165-148-8-914-b29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41379-019-0428-0","article-title":"Diagnostic utility of STAT6(YE361) expression in classical Hodgkin lymphoma and related entities","volume":"33","author":"Van Slambrouck","year":"2020","journal-title":"Mod Pathol"},{"issue":"3","key":"2024080115202971300_i1543-2165-148-8-914-b30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000581","article-title":"GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities","volume":"27","author":"Kezlarian","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"23","key":"2024080115202971300_i1543-2165-148-8-914-b31","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"2024080115202971300_i1543-2165-148-8-914-b32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2024080115202971300_i1543-2165-148-8-914-b33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.anndiagpath.2014.03.007","article-title":"Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma","volume":"18","author":"Wang","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"13","key":"2024080115202971300_i1543-2165-148-8-914-b34","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2024080115202971300_i1543-2165-148-8-914-b35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum Pathol"},{"issue":"12","key":"2024080115202971300_i1543-2165-148-8-914-b36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41379-020-0616-y","article-title":"Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers","volume":"33","author":"El Hussein","year":"2020","journal-title":"Mod Pathol"},{"issue":"20","key":"2024080115202971300_i1543-2165-148-8-914-b37","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","article-title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"133","author":"Borchmann","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2024080115202971300_i1543-2165-148-8-914-b38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood-2017-02-766121","article-title":"Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma","volume":"130","author":"Fanale","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2024080115202971300_i1543-2165-148-8-914-b39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/00000478-199011000-00004","article-title":"Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin\u2019s disease is a large B-cell lymphoma in evolution","volume":"14","author":"Chittal","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2024080115202971300_i1543-2165-148-8-914-b40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","article-title":"Nodular paragranuloma can transform into high-grade malignant lymphoma of B type","volume":"20","author":"Hansmann","year":"1989","journal-title":"Hum Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/8\/914\/3414100\/i1543-2165-148-8-914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/8\/914\/3414100\/i1543-2165-148-8-914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:37Z","timestamp":1764790837000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/148\/8\/article-p914.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2023-0133-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,7]]}}}